1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe NIDDK R21 page is a general overview of the R21 mechanism and does not contain specific sickle cell disease funding opportunity details or deadlines.
NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
R21: NIH Exploratory / Developmental Research Grant Award - NIDDK R21: NIH Exploratory / Developmental Research Grant Award The R21 grant mechanism encourages the development of new research activities in categorical program areas. NIDDK does not participate in the Parent R21 funding announcements . Applications must be submitted through an appropriate, targeted Notice of Funding Opportunity.
Current opportunities are in the areas of: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) Applicants should review “Eligibility Information” in the targeted funding opportunity. Applicants should review “Key Dates” in the targeted funding opportunity.
Potential applicants are strongly encouraged to contact “Agency Contacts” listed in the targeted funding opportunity before applying. Last Reviewed September 2025
According to the current listing, eligibility includes: Higher education institutions including HBCUs, nonprofits, for-profits. Confirm the full requirements in the official notice before applying.
The current listing shows $275,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) are due January 7, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.